Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1132-1138

  Shengqiang, Li ^a,b,c,d   Chongguang, Liu ^a,b,c,d   Klimov, Alexander ^a,b,c,d   Subbarao, Kanta ^a,b,c,d   Perdue, Michael L ^a,b,c,d   Delia, Mo ^a,b,c,d   Yaying, Ji ^a,b,c,d   Woods, Leslie ^a,b,c,d   Hietala, Sharon ^a,b,c,d   Bryant, Martin ^a,b,c,d  

^a MEDIMMUNE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d SE Poultry Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; INFLUENZA VACCINE; RECOMBINANT VACCINE;

ADOLESCENT; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CHICKEN; FEMALE; FERRET; IMMUNOGENICITY; INFLUENZA VIRUS; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS ATTENUATION; VIRUS RECOMBINANT;

EID: 0033006537     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314713     Document Type: Article

References (29)

1. 1. Webster RG, Laver WG. Studies of the origin of pandemic influenza. Antigenic analysis of A 2 influenza viruses isolated before and after appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits. Virology 1972;48:433-44.
2. 2. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. On the origin of the human influenza subtypes H2N2 and H3N2. Virology 1978;87:13-20.
3. 3. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of PBI of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989;63: 4603-8.
4. 4. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with fatal respiratory illness. Science 1998;279:393-6.
5. 5. Claas ECJ, Osterhaus ADME, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351:472-7.
6. 6. Webster RG, Geraci J, Petursson G, Skirnisson K. Conjunctivitis in human beings caused by influenza A virus of seals [letter], N Engl J Med 1981; 304:911.
7. 7. Kurtz J, Manvell RJ, Banks J. Avian influenza viruses isolated from human with conjunctivitis. Lancet 1996:348:901-2.
8. 8. Banks J, Speidel E, Alexander DJ. Characterization of an avian influenza A virus isolated from human - is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch Virol 1998;143:781-7.
9. 9. Cox NJ. H5N1 influenza update [abstract S-114]. Program and abstracts in the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego), 24-27 September 1998.
10. 10. Bosch FX, Garten W, Klenk HD, Rott R. Proteolytic cleavage of influenza virus hemagglutinin: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza virus. Virology 1981:113:725-35.
11. 11. Webster RG, Rott R. Influenza virus A pathogenicity: the pivotal role of the hemagglutinin. Cell 1987;50:665-6.
12. 12. Perdue M, Garcia M, Senne D, Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avain influenza viruses. Virus Res 1997;49:173-86.
13. 13. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-71.
14. 14. Suarez DL, Perdue ML, Cox N, et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol 1998;72:6678-88.
15. 15. Webster RG, Zhou N, Guan Y, et al. Characterization of H5N1 and H9N2 influenza viruses isolated from domestic poultry in Hong Kong [abstract 44]. In: Workshop: structure and replication of negative strand RNA viruses (Evanston, IL), 1998.
16. 16. Maassab HF, Shaw MW, Heilman CA. Live influenza virus vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: WB Saunders, 1994:781-801.
17. 17. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998;338:1405-12.
18. 18. Enami M, Luytjes W, Krystal M, Palese P. Introduction of site specific mutations into the genome of influenza virus. Proc Natl Acad Sci USA 1990;87:3802-5.
19. 19. Enami M, Palese P. High-efficiency formation of influenza virus transfectants. J Virol 1991;65:2711-13.
20. 20. Li S, Xu M, Coelingh K. Electroporation of influenza virus ribonucleoprotein complexes for rescue of the nucleoprotein and matrix genes. Virus Res 1995;37:153-61.
21. 21. Recommendations regarding avian influenza. Proceedings of the 98th annual meeting of United States Animal Health Association. Washington, DC: US Department of Agriculture, 1994:522.
22. 22. Dowdle W, Schild GC. Laboratory propagation of human influenza viruses, experimental host range, and isolation from clinical material. In: Kilbourne ED, ed. The Influenza viruses and influenza. New York: Academic Press, 1975:243-68.
23. 23. Garcia M, Crawford JM, Latimer JW, Rivera-Cruz E, Perdue ML. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avain influenza viruses from Mexico. J Gen Virol 1996;77:1493-504.
24. 24. Schmidt NJ, Emmons R. Diagnostic procedures for viral, rickettsial and chlamydial infections. Washington, DC: American Public Health Association, 1988:19-20.
25. 25. Smith W, Andrew CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933;1:66-8.
26. 26. Maassab HF, Kendal AP, Abrams GD, Monto AS. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis 1982;146: 780-90.
27. 27. Keitel WA, Piedra PA. Live cold-adapted, reassortant influenza vaccines. In: Nicholson, Webster RG, Hay A, eds. Textbook of influenza. Oxford, UK: Blackwell Science, 1998:373-90.
28. 28. Whitaker-Dowling P, Maassab HF, Younger JS. Dominant-negative mutants as antiviral agents: simultaneous infection with the cold-adapted live-virus vaccine for influenza A protects ferrets from disease produced by wild-type influenza A. J Infect Dis 1991;164:1200-2.
29. 29. Youngner JS, Treanor JJ, Betts RF, Whitaker-Dowling P. Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild type influenza infection in humans. J Clin Microbiol 1994;32:750-4.